Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

As of 28-Aug, Gujarat Kidney & Super Speciality Ltd's stock price is rising, currently at Rs. 160.85, reflecting a change of Rs. 6.95 or 4.52% increase. This upward movement is supported by several factors. The stock has outperformed the benchmark Sensex, which has seen a decline of 0.36% over the past week, while Gujarat Kidney's stock has increased by 5.27% in the same period. Over the last month, the stock has shown a remarkable gain of 26.65%, significantly higher than the Sensex's modest increase of 0.65%.Today, the stock reached a new 52-week and all-time high of Rs. 163.5, marking a 6.24% increase intraday. Additionally, the stock has been on a consecutive gain streak for the last two days, accumulating a total return of 5.65%. The trading volume has also seen a rise, with a delivery volume of 2.96 lacs on 27 August, which is up by 6.52% compared to the 5-day average, indicating increased investor participation.Moreover, Gujarat Kidney is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong bullish trend. The liquidity of the stock is adequate for trading, further supporting its price rise. Overall, these factors contribute to the positive momentum in the stock price of Gujarat Kidney & Super Speciality Ltd.

Which are the latest news on Gujarat Kidney?

Gujarat Kidney & Super Speciality Ltd Gains 5.27%: 2 Key Factors Driving the Surge Broad-Based Technical Strength Lifts Gujarat Kidney & Super Speciality Ltd to 52-Week High of Rs 163.05

Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

Based on the current analysis of Gujarat Kidney & Super Speciality Ltd, it would be prudent to hold your position in the company for now. The company demonstrates a strong ability to service its debt, highlighted by a low Debt to EBITDA ratio of 1.08 times. This indicates financial stability. Additionally, the recent growth in operating profit by 80.69% and a significant increase in PAT over the last six months suggest positive momentum. The net sales have also shown improvement, reaching Rs 64.87 crore.However, it's important to note that the company has experienced stagnant net sales and operating profit growth at an annual rate of 0%. Furthermore, the valuation appears high with a Price to Book Value of 4.8, especially given a relatively low return on equity (ROE) of 6.1. The lack of investment from domestic mutual funds, which hold 0% of the company, may indicate a lack of confidence at current price levels.Considering these factors, holding your investment seems to be the most sensible approach while monitoring the company's performance and market sentiment closely.

What does Gujarat Kidney do?

Overview:Gujarat Kidney & Super Speciality Ltd operates in the hospital industry and is classified as a micro-cap company.History:The company was incorporated in 2019 under the name Vihaan Medicare Private Limited and later changed its name to Gujarat Kidney and Super Speciality Private Limited in September 2023. The most recent quarterly results report net sales and net profit for the period ending March 2026.Financial Snapshot:- Net Sales: 31 Cr (Quarterly Results - Mar 2026)- Net Profit: 5 Cr (Quarterly Results - Mar 2026)- Market Cap: INR 1,054 Cr (Micro Cap)Key Metrics:- P/E: 69.00- Industry P/E: 67- Dividend Yield: 0.00%- Debt Equity: -0.11- Return on Equity: 6.14%- Price to Book: 4.16Contact Details:Registrar Address: Not available.

Who are the peers of the Gujarat Kidney?

Peers: The peers of Gujarat Kidney are Dr Agarwal's Eye, KMC Speciality, Shalby, GPT Healthcare, Asarfi Hospital, Lotus Eye Hospit, Unihealth Hosp, Chandan Healthca, and Aprameya Enginee.Quality Snapshot: Excellent management risk is observed at KMC Speciality and GPT Healthcare, while Average management risk is found at Dr Agarwal's Eye, Asarfi Hospital, Unihealth Hosp, Chandan Healthca, and the rest. Below Average management risk is noted at Shalby and Lotus Eye Hospit. In terms of Growth, Excellent growth is seen at Unihealth Hosp and Chandan Healthca, Good growth at Dr Agarwal's Eye, KMC Speciality, Asarfi Hospital, and the rest, while Below Average growth is present at Shalby, GPT Healthcare, and Aprameya Enginee. For Capital Structure, Excellent capital structure is noted at KMC Speciality and GPT Healthcare, Good capital structure at Asarfi Hospital, Shalby, Lotus Eye Hospit, and Chandan Healthca, while Average capital structure is found at Dr Agarwal's Eye and the rest.Return Snapshot: Asarfi Hospital has the highest 1-year return at 87.88%, while Shalby has the lowest at -24.54%. Gujarat Kidney's 1-year return is not available for comparison. Additionally, Shalby and GPT Healthcare have negative six-month returns.

GKSL Share Price | Gujarat Kidney & Super Speciality Ltd Stock Analysis & Recommendation

Key Events This Week

24 Aug: Stock opens at Rs.152.60, slight decline amid flat Sensex

27 Aug: Price rebounds with 1.08% gain to Rs.153.90 despite Sensex dip

28 Aug: New 52-week high at Rs.163.05 and all-time high near Rs.161.55

28 Aug: Week closes at Rs.160.85, up 5.27% vs Sensex down 0.05%

Week Open

Rs.152.80

Week CloseRead full news article

Broad-Based Technical Strength Lifts Gujarat Kidney & Super Speciality Ltd to 52-Week High of Rs 163.05

With a decisive surge to Rs 163.05 on 28 Aug 2026, Gujarat Kidney & Super Speciality Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum.

Read full news article

Strong Momentum Meets Stretched Valuations as Gujarat Kidney & Super Speciality Ltd Reaches All-Time High

Extending its recent rally, Gujarat Kidney & Super Speciality Ltd touched a fresh all-time high of Rs 161.55 on 28 Aug 2026, marking a 4.58% gain on the day and outperforming the Sensex by over 4 percentage points.

Read full news article

[ { "link": "quarterly", "btn_text": "All Quarterly Results", "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ", "rhs": [ { "prefix": "Net Sales ", "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.00% vs -5.33% in Mar 2026", "dir": 1 }, { "prefix": "Standalone Net Profit ", "suffix": "QoQ Growth in quarter ended Jun 2026 is 48.91% vs -41.20% in Mar 2026", "dir": 1 } ], "table": { "header": [ "Jun'26", "Mar'26", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "9.24", "val2": "9.24", "chgp": "", "chgp_class": "neutral" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "3.00", "val2": "1.57", "chgp": "91.08%", "chgp_class": "positive" }, { "field": "Interest", "val1": "0.35", "val2": "0.50", "chgp": "-30.00%", "chgp_class": "positive" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "2.04", "val2": "1.37", "chgp": "48.91%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "32.47%", "val2": "16.99%", "chgp": "15.48%", "chgp_class": "positive" } ] } }, { "link": "half-yearly", "btn_text": "All Half Yearly Results", "header": "Half Yearly Results Snapshot (Standalone) - Sep'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Sep'25", "", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "21.09", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "10.42", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Interest", "val1": "0.36", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "6.20", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "49.41%", "val2": "NA%", "chgp": "NA", "chgp_class": "neutral" } ] } }, { "link": "nine-monthly", "btn_text": "All Nine Monthly Results", "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Dec'25", "", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "30.85", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "14.56", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Interest", "val1": "0.65", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "8.53", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "47.20%", "val2": "NA%", "chgp": "NA", "chgp_class": "neutral" } ] } }, { "link": "annual", "btn_text": "All Annual Results", "header": "Annual Results Snapshot (Standalone) - Mar'26", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Mar'26", "Mar'25", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "40.10", "val2": "35.17", "chgp": "14.02%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "16.14", "val2": "15.45", "chgp": "4.47%", "chgp_class": "positive" }, { "field": "Interest", "val1": "1.15", "val2": "0.53", "chgp": "116.98%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "9.90", "val2": "9.11", "chgp": "8.67%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "40.25%", "val2": "43.93%", "chgp": "-3.68%", "chgp_class": "negative" } ] } } ]